Malignant germ cell tumor of the cervix uteri

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

Regulatory Watchboard

10 events

Jan 2026MRinRT: Swansea University and SWWCC Collaboration Study.

Swansea Bay University Health Board

TrialNOT YET RECRUITING

Nov 2025Exploratory Study of Inhaled Afatinib Dimaleate PK Profile

Petrov, Andrey — PHASE1

TrialNOT YET RECRUITING

Sep 2025Contrast-enhanced Ultrasound for Sentinel Node Detection

The Netherlands Cancer Institute — PHASE2, PHASE3

TrialRECRUITING

Dec 2024EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

Case Comprehensive Cancer Center — NA

TrialRECRUITING

May 2024Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

Charite University, Berlin, Germany — PHASE2

TrialNOT YET RECRUITING

Apr 2024A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Ipsen — PHASE1, PHASE2

TrialRECRUITING

Jan 2024A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

M.D. Anderson Cancer Center — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Aug 2023Survival Monitoring in Russian Cancer Registries

N.N. Petrov National Medical Research Center of Oncology

TrialACTIVE NOT RECRUITING

Mar 2023Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1

TILT Biotherapeutics Ltd. — PHASE1

TrialACTIVE NOT RECRUITING

Feb 2022A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

Amgen — PHASE1, PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

Exkivity

Takeda Development Center Americas, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Exkivity

(mobocertinib)Orphan drugaccelerated

Takeda Development Center Americas, Inc.

Lynparza

(olaparib)Orphan drugstandard

AstraZeneca Pharmaceuticals LP

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

12.1 Mechanism of Action Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are ...

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Malignant germ cell tumor of the cervix uteri.
Search all trials →

Search clinical trials for Malignant germ cell tumor of the cervix uteri →

Recent News & Research

No recent news articles indexed yet for Malignant germ cell tumor of the cervix uteri.
Search PubMed for Malignant germ cell tumor of the cervix uteri →

Browse all Malignant germ cell tumor of the cervix uteri news →

Specialist Network

Top 6 by expertise

Vincent Chung, MD

City of Hope Medical Center

📍 DUARTE, CA

Score 96 trials

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Score 819 trials

Susan K Peterson

M.D. Anderson Cancer Center

Score 31 trial17 pubs

Rob Kimmerling, Phd

Travera Inc

Sharon Manne

Rutgers Cancer Institute of New Jersey

Score 33 trials2 pubs

Mark Stevens, Phd

Travera Inc

View all Malignant germ cell tumor of the cervix uteri specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles